Suicidality and Cannabidiol: Opportunities and Challenges.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Cannabidiol (CBD) is increasingly recognized for its therapeutic potential in neuropsychiatric disorders.
• Existing research highlights CBD's efficacy in managing psychotic symptoms, anxiety, and substance use disorders.
• These conditions frequently co-occur with suicidality, yet dedicated suicide research involving CBD is notably absent.

Purpose of the Study:

• To review the current evidence regarding cannabidiol's (CBD) effects on suicidality.
• To explore potential factors contributing to the limited investigation of CBD in suicide research.
• To propose directions for future research on CBD and suicidality.

Main Methods:

• This study is a perspective piece, synthesizing existing literature.
• It involves an overview of current research findings on CBD and related conditions.
• Analysis of potential barriers to suicide-focused CBD research.

Main Results:

• Significant research exists on CBD for psychosis, anxiety, and substance use disorders.
• A considerable gap exists in the literature concerning CBD's direct impact on suicidality.
• Potential reasons for this research gap are discussed.

Conclusions:

• While CBD shows therapeutic promise for conditions linked to suicidality, its specific role in suicide prevention or treatment remains under-explored.
• Further research is crucial to understand CBD's potential benefits and risks in the context of suicidality.
• Recommendations are provided to guide future investigations into cannabidiol and suicide.